These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4983529)

  • 1. Human M-proteins with antibody activity for nitrophenyl ligands.
    Terry WD; Boyd MM; Rea JS; Stein R
    J Immunol; 1970 Jan; 104(1):256-9. PubMed ID: 4983529
    [No Abstract]   [Full Text] [Related]  

  • 2. Myeloma proteins with anti-hapten antibody activity: epsilon-2,4-dinitrophenyl lysine binding by the protein produced by mouse plasmacytoma MOPC-460.
    Jaffe BM; Eisen HN; Simms ES; Potter M
    J Immunol; 1969 Oct; 103(4):872-4. PubMed ID: 5349739
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic control of the specificity of anti-DNP antibodies. II. Differences in the specificity of anti-DNP antibody produced by several inbred strains of mice.
    Paul WE; Yoshida T; Benacerraf B
    J Immunol; 1970 Aug; 105(2):314-21. PubMed ID: 4194305
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of antibody-hapten equilibrium constants by an ammonium sulfate precipitation technique.
    Stupp Y; Yoshida T; Paul WE
    J Immunol; 1969 Sep; 103(3):625-7. PubMed ID: 5817170
    [No Abstract]   [Full Text] [Related]  

  • 5. Hapten binding studies on mouse IgA myeloma proteins with antibody activity.
    Sher A; Tarikas H
    J Immunol; 1971 May; 106(5):1227-33. PubMed ID: 4995750
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental approaches to homogenous antibody populations. Myeloma proteins with antihapten antibody activity.
    Eisen HN; Michaelides MC; Underdown BJ; Schulenburg EP; Simms ES
    Fed Proc; 1970; 29(1):78-84. PubMed ID: 5412396
    [No Abstract]   [Full Text] [Related]  

  • 7. Alterations in isotypic and allotypic immunoglobulin antigens induced by chemical modification.
    Messner RP; Natvig JB; Ein D; Wlliams RC
    J Immunol; 1971 Mar; 106(3):644-8. PubMed ID: 4100687
    [No Abstract]   [Full Text] [Related]  

  • 8. 2,4-dinitrophenyl-hapten specific hemolytic plaque-in-gel formation by mouse myeloma (MOPC-315) cells.
    Yamada H; Yamada A; Hollander VP
    J Immunol; 1970 Jan; 104(1):251-5. PubMed ID: 4904002
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental approaches tohomogenous antibody populations. iIndividual antigenic specificity, cross specificity and diversity of human antibodies.
    Kunkel HG
    Fed Proc; 1970; 29(1):55-8. PubMed ID: 4983814
    [No Abstract]   [Full Text] [Related]  

  • 10. Reactivity of normal shark immunoglobulins with nitrophenyl ligands.
    Leslie GA; Clem LW
    J Immunol; 1970 Dec; 105(6):1547-52. PubMed ID: 4098506
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of antibody activity in human myeloma proteins.
    Yoo TJ; Franklin EC
    J Immunol; 1971 Aug; 107(2):365-7. PubMed ID: 4398183
    [No Abstract]   [Full Text] [Related]  

  • 12. Atypical antigenic properties of a gamma-A myeloma protein.
    Osterland CK; Chaplin H
    J Immunol; 1966 May; 96(5):842-8. PubMed ID: 5913755
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibodies of restricted heterogeneity for structural study.
    Haber E
    Fed Proc; 1970; 29(1):66-71. PubMed ID: 4391650
    [No Abstract]   [Full Text] [Related]  

  • 14. Ultrastructural and immunochemical characterizatiog of one case of IgD myeloma.
    Mazzei D; Sessa A; Ortolani C; Cattaneo R; Mignone V
    Prog Immunobiol Stand; 1970; 4():174-8. PubMed ID: 4991581
    [No Abstract]   [Full Text] [Related]  

  • 15. [Binding of beta-lipoprotein by an IgA paraprotein: an antigen-antibody reaction?].
    Noseda G; Bütler R; Schlumpf E; Brunner E; Riesen W
    Schweiz Med Wochenschr; 1971 Jun; 101(24):893-9. PubMed ID: 5004031
    [No Abstract]   [Full Text] [Related]  

  • 16. Determinant specificity of cellular immune responses.
    Paul WE
    Fed Proc; 1970; 29(1):224-5. PubMed ID: 5412395
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new method for the determination and characterization of monoclonal immunoglobulins (double line method)].
    Barandun S; Carrel S; Gerber H; Morell A; Riesen W; Skvaril F
    Schweiz Med Wochenschr; 1971 Jul; 101(26):955-64. PubMed ID: 5004077
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoelectrophoretic analysis of protein disorders of the gamma-fraction M-component in 21 cases of multiple myeloma.
    Kraj M; Kacperska E; Snigurowicz J
    Arch Immunol Ther Exp (Warsz); 1969; 17(3):356-65. PubMed ID: 5802833
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the control of antibody synthesis. V. Effect of nonspecific modification of the magnitude of the immune response on the affinity of the antibody synthesized.
    Mond J; Kim YT; Siskind GW
    J Immunol; 1974 Mar; 112(3):1255-63. PubMed ID: 4590704
    [No Abstract]   [Full Text] [Related]  

  • 20. Mouse myeloma proteins with antihapten antibody acitivity. The protein produced by plasma cell tumor MOPC-315.
    Eisen HN; Simms ES; Potter M
    Biochemistry; 1968 Nov; 7(11):4126-34. PubMed ID: 4177521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.